Bioxytran, Inc. BIXT
Set alert
0.02 USD 0.00 +1.39%
At close · Oct 29
0.0205 Day range 0.0232
0.0201 52-week range 0.09
- YTD
- -72.98%
- 1 year
- -70.74%
- Open
- 0.0205
- Prev close
- 0.0202
- Mkt cap
- 2.35M
- Vol
- 43.50K
- Avg vol
- 100.02K
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.0205
- High
- 0.0232
- Earnings
- Nov 2, 2023
2Y chart
Signals (102)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 1 day ago |
| SMA: Bearish | Oct 28, 2026 | 3 days ago |
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| SMA: Bearish | Oct 26, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 26, 2026 | 5 days ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | May 27, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 8, 2026 | 6 months ago |
| SMA: Bearish | Mar 31, 2026 | 7 months ago |
| SMA: Bullish | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 25, 2026 | 7 months ago |
| SMA: Bullish | Mar 24, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 20, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 12, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 10, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| RSI: Oversold | Jan 30, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 8, 2026 | 9 months ago |
| SMA: Bearish | Jan 6, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 5, 2026 | 9 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 10, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| SMA: Bullish | Nov 18, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 11 months ago |
| SMA: Bullish | Nov 6, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 30, 2025 | 1 year ago |
| RSI: Oversold | Oct 27, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 17, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Sep 12, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 2, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 29, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 5, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 30, 2025 | 1 year ago |
| SMA: Bearish | May 29, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 22, 2025 | 1 year ago |
| MACD: Buy Signal | May 21, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 17, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| RSI: Overbought | Mar 14, 2025 | 1 year ago |
| RSI: Overbought | Mar 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 6, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 6, 2025 | 1 year ago |
| SMA: Bearish | Feb 4, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 27, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 23, 2025 | 1 year ago |
| SMA: Bearish | Jan 16, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 10, 2025 | 1 year ago |
| RSI: Oversold | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 2, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 20, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 19, 2024 | 1 year ago |
Next earnings
Nov 2, 2023
Expected Nov 2, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 28, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| Apr 19, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Mar 22, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 2, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Jul 31, 2023 | Jun 1, 2023 | 0.00 | -0.01 | — | — |
News
- Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar
- Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
- Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research
- Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
- Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Decline in Short Interest
- BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT
- Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
- Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
- Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
- Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update
Your note
Sign in to keep a note on BIXT — it syncs with the Stock Master app.